These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6339926)

  • 1. Drug therapy. Pindolol: a new beta-adrenoceptor antagonist with partial agonist activity.
    Frishman WH
    N Engl J Med; 1983 Apr; 308(16):940-4. PubMed ID: 6339926
    [No Abstract]   [Full Text] [Related]  

  • 2. Pindolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.
    Golightly LK
    Pharmacotherapy; 1982; 2(3):134-47. PubMed ID: 6133267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-adrenoceptor-blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol.
    Meier J
    Cardiology; 1979; 64 Suppl 1():1-13. PubMed ID: 42483
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy: atenolol and timolol, two new systemic beta-adrenoceptor antagonists.
    Frishman WH
    N Engl J Med; 1982 Jun; 306(24):1456-62. PubMed ID: 7043268
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of tachycardias and arrhythmias. Studies using Visken].
    Färber A
    Med Welt; 1974 Sep; 25(35):1369-74. PubMed ID: 4138154
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new beta-blocker, LB 46--Visken].
    Oulhaci M; Merad B; Toumi N; Ait-Amar M; Boudjellab A; Issad M; Piva G
    Tunis Med; 1973 Nov; 51(6):369-73. PubMed ID: 4137366
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution to the pharmacology of the beta-adrenolytics].
    Wagner J
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2442-8. PubMed ID: 4394708
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prindolol in the therapy of arterial hypertension].
    Cocco G; Jerie P
    Boll Soc Ital Cardiol; 1975; 20(11):1449-55. PubMed ID: 1234443
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of digitalis on pindolol activity in exercise-induced cardiac failure in patients with coronary disease (author's transl)].
    Oeff M; Beck OA; Hochrein H
    Dtsch Med Wochenschr; 1979 Jan; 104(3):98-103. PubMed ID: 759158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of supraventricular arrhythmias using the beta-blockader Visken].
    Zdichynec B
    Z Arztl Fortbild (Jena); 1977 May; 71(10):478. PubMed ID: 910468
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phrmacodynamic principles underlying the specific therapy of coronary vascular disease].
    Kraupp O
    Wien Klin Wochenschr; 1973 Feb; 85(8):115-22. PubMed ID: 4144095
    [No Abstract]   [Full Text] [Related]  

  • 17. Nadolol: a new beta-adrenoceptor antagonist.
    Frishman WH
    N Engl J Med; 1981 Sep; 305(12):678-82. PubMed ID: 6115316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781].
    Frank J; Dolder M; Gertsch M; Althaus U; Gurtner HP
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1740-3. PubMed ID: 715414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pindolol in the treatment of arrhythmias caused by exertion].
    Giordano A; Tamiz A; Schiavo B; Rossi P
    Minerva Med; 1979 Nov; 70(51):3499-501. PubMed ID: 42861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta receptor antagonists--pharmacologic characteristics and mechanism of action in cardiovascular diseases].
    Langnickel R; Bluth R
    Z Arztl Fortbild (Jena); 1984; 78(7):255-61. PubMed ID: 6145258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.